JOSEPH MCTYGUE: Open Payments
NPI 1396410759 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 10 payments from 7 companies in 2025. Trend: 2023 $190 · 2024 $237 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $50 |
| Novo Nordisk Inc | 2 | $36 |
| Ascendis Pharma Endocrinology Inc | 2 | $33 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Sequel Med Tech, LLC | 1 | $23 |
| Ascensia Diabetes Care Us Inc. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
Products named: MINIMED 780G, Yorvipath, REZDIFFRA, TWIIST, UNITHROID, Ozempic, Rybelsus.
Industry payments across NE — which companies pay providers there.
